Testicular Mesothelioma: An Analysis of Epidemiology, Patient Outcomes, and Prognostic Factors.

To characterize demographic features, clinical characteristics, and oncologic outcomes of mesothelioma of the testis.

A population based search was performed using the National Cancer Institute's SEER 18 database. Patients diagnosed with malignant mesothelioma of the male genital organs from 1973 to 2015 were identified. Data on patient age, race, tumor laterality, histologic subtype, tumor extent, tumor size, tumor grade, treatment, cause of death, and survival months was collected. Primary outcomes were overall survival (OS) and disease-specific survival (DSS).

A total of 113 patients with testicular mesothelioma were identified. The 5-year OS and DSS for all patients was 49% and 58%, and the 10-year OS and DSS was 33% and 45%, respectively. Biphasic mesotheliomas were associated with worse OS compared to general mesotheliomas and epithelioid subtypes (p=0.043 and p=0.039, respectively). Median survival time was not reached in patients with T1 disease while OS was 1.7 years and DSS was 1.8 years for patients with T4 disease (OS p=0.002, DSS p<0.001). Tumors greater than or equal to 4 centimeters were associated with worse OS and DSS (OS p=0.025, DSS p=0.047).

This rare malignancy has significant mortality, with poor survival associated with biphasic subtypes, higher disease stage, and a critical tumor size cutoff of 4 centimeters.

Urology. 2019 Jan 19 [Epub ahead of print]

Azadeh Nazemi, Nima Nassiri, Shane Pearce, Siamak Daneshmand

USC Institute of Urology, Los Angeles, CA, USA; University of Southern California, Los Angeles, CA, USA. Electronic address: ., USC Institute of Urology, Los Angeles, CA, USA; University of Southern California, Los Angeles, CA, USA; USC/Norris Comprehensive Cancer Center, Los Angeles, CA, USA. Electronic address: ., USC Institute of Urology, Los Angeles, CA, USA; University of Southern California, Los Angeles, CA, USA; USC/Norris Comprehensive Cancer Center, Los Angeles, CA, USA. Electronic address: ., USC Institute of Urology, Los Angeles, CA, USA; University of Southern California, Los Angeles, CA, USA; USC/Norris Comprehensive Cancer Center, Los Angeles, CA, USA. Electronic address: .

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe